Vimarsana
Biggest News Aggregation in the World

Page 2 - Nasdaq Nbse News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq Nbse. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Nbse Today - Breaking & Trending Today

Insider Selling: NeuBase Therapeutics, Inc. (NASDAQ:NBSE) Major Shareholder Sells 74,852 Shares of Stock - Vimarsana News

Insider Selling: NeuBase Therapeutics, Inc. (NASDAQ:NBSE) Major Shareholder Sells 74,852 Shares of Stock

NeuBase Therapeutics, Inc. (NASDAQ:NBSE – Get Free Report) major shareholder Corp Symetryx sold 74,852 shares of the business’s stock in a transaction dated Thursday, September 7th. The stock was sold at an average price of $1.80, for a total transaction of $134,733.60. Following the transaction, the insider now owns 605,149 shares in the company, valued […]

FY2023 EPS Estimates for NeuBase Therapeutics, Inc. (NASDAQ:NBSE) Raised by Analyst - Vimarsana News

FY2023 EPS Estimates for NeuBase Therapeutics, Inc. (NASDAQ:NBSE) Raised by Analyst

NeuBase Therapeutics, Inc. (NASDAQ:NBSE – Free Report) – Equities researchers at Chardan Capital increased their FY2023 earnings per share estimates for shares of NeuBase Therapeutics in a research note issued to investors on Wednesday, August 16th. Chardan Capital analyst K. Nakae now forecasts that the company will post earnings per share of ($5.19) for the […]

NeuBase Therapeutics, Inc. (NASDAQ:NBSE) Short Interest Update - Vimarsana News

NeuBase Therapeutics, Inc. (NASDAQ:NBSE) Short Interest Update

NeuBase Therapeutics, Inc. (NASDAQ:NBSE – Get Free Report) was the target of a large growth in short interest in the month of June. As of June 30th, there was short interest totalling 71,500 shares, a growth of 108.5% from the June 15th total of 34,300 shares. Based on an average trading volume of 72,200 shares, […]

NeuBase Therapeutics, Inc. (NASDAQ:NBSE) Short Interest Down 93.8% in June - Vimarsana News

NeuBase Therapeutics, Inc. (NASDAQ:NBSE) Short Interest Down 93.8% in June

NeuBase Therapeutics, Inc. (NASDAQ:NBSE – Free Report) saw a large drop in short interest in the month of June. As of June 15th, there was short interest totalling 34,300 shares, a drop of 93.8% from the May 31st total of 554,800 shares. Based on an average trading volume of 62,600 shares, the short-interest ratio is […]

CM Management LLC Sells 100,000 Shares of NeuBase Therapeutics, Inc. (NASDAQ:NBSE) - Vimarsana News

CM Management LLC Sells 100,000 Shares of NeuBase Therapeutics, Inc. (NASDAQ:NBSE)

CM Management LLC lessened its holdings in NeuBase Therapeutics, Inc. (NASDAQ:NBSE – Get Rating) by 22.2% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 350,000 shares of the company’s stock after selling 100,000 shares during the period. CM Management LLC owned approximately 1.06% […]

Source: wkrb13.com